CN Creative

CN Creative acquired by British American Tobacco

Admin — Wed, 19 Dec 2012 10:13:49 +0000

CN Creative announced today that it has been acquired by British American Tobacco as part of the FTSE 100 Company’s long term commitment to tobacco harm reduction. CN Creative, which has its own research and development facilities, currently has several e-cigarette products on the market as well as new, innovative e-cigarette...

The post CN Creative acquired by British American Tobacco appeared first on CN Creative.

Smoking Cessation Quit Rates Soar in Sandwell

Admin — Thu, 11 Oct 2012 09:21:09 +0000

Sandwell has amongst the highest rates of social deprivation and health inequalities in the West Midlands.

The post Smoking Cessation Quit Rates Soar in Sandwell appeared first on CN Creative.

CNC Awarded ‘Best Business’ Accolade

Admin — Tue, 11 Sep 2012 11:28:04 +0000

CN Creative wins ‘Best Business Award’ for Intellicig success.

The post CNC Awarded ‘Best Business’ Accolade appeared first on CN Creative.

Quit Direct Working With Asda Pharmacy

Admin — Tue, 31 Jul 2012 11:09:23 +0000

Asda have more than 200 in-store pharmacies across the UK, offering a range of services that help customers lead a healthier lifestyle.

The post Quit Direct Working With Asda Pharmacy appeared first on CN Creative.

CN Creative Advances Regulatory Initiatives For Its Nicadex™ And Intellicig® Harm Reduction/Smoking Cessation Products

Admin — Wed, 30 May 2012 10:59:51 +0000

CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses.

The post CN Creative Advances Regulatory Initiatives For Its Nicadex™ And Intellicig® Harm Reduction/Smoking Cessation Products appeared first on CN Creative.

CN Creative Appoints Chief Financial Officer

Admin — Wed, 04 Apr 2012 13:32:49 +0000

CN Creative today announced that Tim Byrne has been appointed Chief Financial Officer.

The post CN Creative Appoints Chief Financial Officer appeared first on CN Creative.

CN Creative Raises ‘Series A’ Funding To Develop First Medically Approved Electronic Inhaler Nicotine Replacement Therapy for Smoking Cessation

Admin — Wed, 25 Jan 2012 09:58:56 +0000

CN Creative today announced it has raised a Series A financing round led by Advent Life Sciences.

The post CN Creative Raises ‘Series A’ Funding To Develop First Medically Approved Electronic Inhaler Nicotine Replacement Therapy for Smoking Cessation appeared first on CN Creative.